Author Archive
-
Mar 28, 2024Michael J. Mitchell is developing lipid nanoparticles to deliver therapy to specific organs such as the lungs and brain. -
Feb 12, 2024A second deaf patient is undergoing the treatment, produced by Eli Lilly, at CHOP on Friday.
